Switzerland/ Big Pharma Investment in Switzerland Continues with CHF 200 million from Takeda
After a Moderna-Lonza production site and a Merck manufacturing facility were set up in western Switzerland, the country continues to attract big pharma capital with a CHF 200 million investment…